Samidorphan L Malate is a synthetic opioid antagonist that functions primarily as a mu-opioid receptor antagonist. It is approved for clinical use in combination with the atypical antipsychotic olanzapine… Read more
Samidorphan L Malate is a synthetic opioid antagonist that functions primarily as a mu-opioid receptor antagonist. It is approved for clinical use in combination with the atypical antipsychotic olanzapine for the treatment of schizophrenia and bipolar I disorder in adults, where it helps mitigate weight gain and metabolic dysfunction associated with antipsychotic therapy. Laboratories utilize high-quality reference standards of Samidorphan L Malate for critical analytical activities, including rigorous impurity profiling and method validation. This category also encompasses essential stable isotope labelled compounds and identified metabolites, which serve as internal standards for precise quantification during quality control procedures and bioanalytical studies. By providing these specialized materials, researchers can ensure accurate assessment of drug substance and product integrity throughout pharmaceutical development.